India to Australia: Naproxen Export Trade Route

The India to Australia Naproxen corridor is one of India's established pharmaceutical export routes, with 33 shipments documented worth a combined $1.1M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 96% of all export value, reflecting the consolidated nature of India's naproxen manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $33.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with naproxen's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 30.2%, placing it at rank #9 among India's top naproxen export destinations globally.

On the import side, key buyers of Indian naproxen in Australia include ARROW PHARMACEUTICALS PTY LTD, APOTEX AUSTRALIA, NOUMED PHARMACEUTICALS PTY LTD and 8 others. ARROW PHARMACEUTICALS PTY LTD is the single largest importer with 9 shipments valued at $506.1K USD.

India's naproxen exports to Australia are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 28 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , SAI PARENTERAL S LIMITED — together account for 100% of total trade value on this route. The average shipment value of $33.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as apo health period pain relief tablet(naproxen sodium 275mg) (10000 packx2x12's=240000 nos) and apo health period pain relief tablet(naproxen sodium 275mg) (9920 packx2x12's=238080 nos), suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ARROW PHARMACEUTICALS PTY LTD is the largest importer with 9 shipments worth $506.1K USD — representing 46% of all naproxen imports from India on this route. A total of 11 buyers are active on this corridor.